MUSIANI, Piero
 Distribuzione geografica
Continente #
NA - Nord America 6.774
EU - Europa 6.233
AS - Asia 3.872
SA - Sud America 191
Continente sconosciuto - Info sul continente non disponibili 19
AF - Africa 11
OC - Oceania 10
Totale 17.110
Nazione #
US - Stati Uniti d'America 6.710
UA - Ucraina 1.448
CN - Cina 1.390
SG - Singapore 1.126
IE - Irlanda 1.030
TR - Turchia 1.030
GB - Regno Unito 985
SE - Svezia 757
FR - Francia 658
DE - Germania 465
IT - Italia 349
FI - Finlandia 273
IN - India 224
BR - Brasile 169
RU - Federazione Russa 164
CA - Canada 53
CZ - Repubblica Ceca 30
BE - Belgio 29
VN - Vietnam 28
EU - Europa 19
GR - Grecia 18
HK - Hong Kong 18
IL - Israele 15
MX - Messico 9
IQ - Iraq 8
AU - Australia 6
IR - Iran 6
PK - Pakistan 6
VE - Venezuela 6
BD - Bangladesh 5
ES - Italia 5
UZ - Uzbekistan 5
LT - Lituania 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AR - Argentina 3
AT - Austria 3
EG - Egitto 3
RO - Romania 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
EC - Ecuador 2
KE - Kenya 2
MA - Marocco 2
NL - Olanda 2
PE - Perù 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 17.110
Città #
Jacksonville 1.443
Chandler 1.249
Dublin 1.025
Southend 818
Singapore 635
Izmir 522
Princeton 492
Nanjing 422
Dearborn 421
Wilmington 346
Cambridge 257
Beijing 218
Ann Arbor 180
Ashburn 160
Nanchang 142
Boardman 139
Woodbridge 130
New York 116
Santa Clara 114
Grevenbroich 99
Altamura 94
Shenyang 71
Hebei 67
Tianjin 62
Houston 61
Chieti 58
Jiaxing 55
Kunming 51
Jinan 42
Norwalk 41
Hangzhou 39
Orange 39
Changsha 37
San Mateo 35
Augusta 32
Helsinki 31
Brno 30
Brussels 27
Toronto 27
Dong Ket 26
Hefei 26
Grafing 24
Guangzhou 22
Los Angeles 22
Romola 19
Washington 19
Andover 18
Ningbo 18
São Paulo 18
Auburn Hills 17
Chicago 17
Leawood 17
London 17
Ottawa 17
Hong Kong 16
Milan 16
Lanzhou 13
Rome 13
Zhengzhou 12
Changchun 11
Taizhou 11
Falls Church 10
Düsseldorf 9
Mexico City 8
Seattle 8
Simi Valley 8
Bari 7
Lanciano 7
Munich 6
Vasto 6
Walnut 6
Frankfurt am Main 5
Fuzhou 5
Haikou 5
Nuremberg 5
Rio de Janeiro 5
Sydney 5
Tappahannock 5
Tashkent 5
The Dalles 5
Baghdad 4
Baotou 4
Belo Horizonte 4
Ferrara 4
Guarulhos 4
Ardabil 3
Asunción 3
Cairo 3
Campinas 3
Chongqing 3
Curitiba 3
Goiânia 3
Istanbul 3
Jülich 3
Kocaeli 3
Monmouth Junction 3
Mumbai 3
Redwood City 3
San Donà di Piave 3
Shanghai 3
Totale 10.401
Nome #
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. 222
Tamoxifene e quercetina inibiscono la proliferazione di cellule neoplastiche polmonari "non small cell" in coltura e nei tumori primitivi. 190
Role of GM-CSF in cryptogenic organizing pneumonia 139
Ruolo della IL-1 nella regolazione della produzione del TGFbeta1 e della IL-8 nei tumori del polmone "non-small cell". 128
Apoptosi spontanea ed indotta da glicocorticoidi nei linfociti T periferici umani 125
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 118
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 113
Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung. 109
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. 106
Transforming growth factor beta1, interleukin-8 and interleukin-1 in human non-small cell lung tumor cell lines and primary tumors. 106
TGF-beta-1 and IL-8 in human long cancer cell lines and primary tumors: constitutive production and modulation by IL-1 105
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 104
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 100
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 99
T3 expression by human thymocytes in culture. 99
Distribution and phenotype of immune cells in normal human gingiva: active immune response versus unresponsiveness. 98
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 97
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids. 95
Growth inhibitory mechanism of quercetin and tamoxifen in human lung cancer cell lines 94
A solid phase radioimmunoassay for the diagnosis of human hydatidosis. 94
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 94
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 93
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 91
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 91
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 91
Cellule immunocompetenti associate alla mucosa nella patologia della cervice uterina dei soggetti HIV-infetti 90
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 90
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 90
Carcinomi polmonari umani: produzione di TGFbeta1 89
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 89
INTERACTION WITH TYPE II ESTROGEN BINDING SITES AND ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN AND QUERCETIN IN HUMAN NON SMALL CELL LUNG CANCER. 89
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 89
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 89
Polymorphonuclear Leukocyte Apoptosis is Inhibited by Platelet-released mediators, Role of TGFbeta-1 88
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 88
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 87
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 87
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 87
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 87
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 87
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 86
IL-10 potentiates the effect of dexamethasone in inhibiting the proliferation of resting, activated and "corticoresistant" human T cells 86
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 85
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients. 85
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 85
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 84
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 84
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 84
Analysis of IL-2-receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer. 83
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 83
Proliferative capabilities of T3-positive thymocytes. 83
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 82
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 82
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors. 82
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 81
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). 81
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 80
Alpha-1-antitrypsin in umbilical cord serum: pi phenotypes and relationships with idiopathic respiratory distress syndrome. 80
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 80
Growth inhibitory effect of quercetin and tamoxifen and presence of type II estrogen-binding sites in human lung cancer cell lines and primary tumors 79
Glucocorticoid inhibitory action on OKT3 stimulated peripheral blood lymphocytes from renal transplant patients. 79
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 79
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. 79
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 79
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 78
Inactivation of the IL-6 gene prevents development of multricentric Castleman's disease in C/EBP beta-deficient mice 78
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 78
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 78
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 78
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome. 78
Neutrophils in anti-cancer immunological strategies: old players in new games 78
Echinococcus granulosus: specific quantification of the two most immunoreactive antigens in hydatid fluids. 78
Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. 78
Alpha-l-antitrypsin deficiency and human pathology. 78
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 78
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 77
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. 77
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 77
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 76
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 76
Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipients. 76
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 76
IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. 76
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 76
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 75
5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory 75
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 75
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 75
Antimetastatic activity of a preventive cancer vaccine. 75
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 75
Alloantisera defining surface antigens on human thymocytes. 75
Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells. 75
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 74
THE ROLE OF ARACHIDONIC ACID METABOLITE PGE2 ON T CELL PROLIFERATIVE RESPONSE. 74
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 74
Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation 74
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 74
Hairy cell leukemia. 74
Echinococcus granulosus: preparation of monosepcific antisera against antigens in sheep hydatid fluid. 74
Immunological prevention of a multigene cancer syndrome. 73
Totale 8.834
Categoria #
all - tutte 67.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020448 0 0 0 0 0 0 0 0 0 123 298 27
2020/20211.618 261 5 246 9 221 340 10 6 135 253 44 88
2021/2022926 18 12 7 122 142 32 33 82 65 30 121 262
2022/20233.423 294 297 164 446 376 773 204 260 446 38 72 53
2023/20241.387 136 49 65 36 104 428 363 40 11 20 14 121
2024/20251.991 224 489 401 75 63 49 36 238 392 24 0 0
Totale 17.416